Luminos® Comprehensive is a 164-gene pan-tumor genomic profiling panel validated as an IVDR-compliant laboratory-developed test (LDT) and deployed in-house at Discovery Life Sciences’ Kassel, Germany facility under Health Institution status. Purpose-built for precision oncology clinical trials, the assay supports enrollment screening, biomarker stratification, and prospective EU clinical use without third-party reference lab routing or performance study overhead. Testing is supported by a full complement of project management, data management, and logistics services working under a robust and compliant quality management system (QMS).